Phil Ferneau

Phil J.
Ferneau is the founder of Borealis Ventures, established in 2002, serving as Managing Director.
Current jobs include Director at Orbit Discovery Ltd. since 2018, Director at Ovation Life Sciences LLC since 2019, Board Director at Amagma, Inc. since 2020, Director at Ankyra Therapeutics, Inc. since 2021, Independent Director at Compass Therapeutics, Inc. since 2015, and Director at T-Cypher Bio Ltd. since 2020.
Former jobs include Director at Avedro, Inc. from 2003 to 2019, Director at Compass Therapeutics LLC, Director at M2S, Inc. from 2003 to 2005, Director at Direct Vet Marketing, Inc., Executive Director-Private Equity Center at Tuck School of Business at Dartmouth, Director at PCD Systems, Inc., Director at Avitide, Inc. from 2013 to 2021, Director at Genextropy, Inc., Director at Olivia Ventures, Inc., Board Director at Covetrus, Inc. from 2010 to 2019, and Investor at GlycoFi, Inc. from 2002 to 2006.
Education includes undergraduate degree from Dartmouth College, MBA from Tuck School of Business at Dartmouth, and graduate degree from the University of Virginia School of Law.